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Introduction
Limb-girdle muscular dystrophy type 2B (LGMD2B) 
and Miyoshi myopathy (MM) are both caused by recessive-
ly inherited mutations in the dysferlin gene1. LGMD2B is 
characterized by the progressive wasting and weakness of 
proximal lower limb-girdle muscles. Meanwhile, the distal 
muscle groups of the limbs and girdle are mostly affected 
in MM. Both disorders have been considered to be due to a 
loss of dysferlin protein at the plasma membrane in muscle 
fibers, which leads to abnormalities in vesicle traffic and 
membrane repair2,3, and are collectively called ‘dysferlinop-
athy’.
Two naturally occurring animal models for LGMD2B, 
SJL/J and A/J mice, have been identified to have mutations 
in the dysferlin gene associated with phenotypic features 
of progressive muscular dystrophy4,5. However, the type of 
dysferlin gene mutation differs between SJL/J and A/J mice. 
SJL/J mice have a splice site mutation that removes a part of 
the highly conserved C2E domain; the domain is known to 
bind to calcium, phospholipids or proteins to trigger signal-
ing events and membrane trafficking4,6,7. On the other hand, 
A/J mice bear a unique ETn retrotransposon insertion near 
the 5’ end (intron 4) of the dysferlin gene5. Interestingly, the 
two strains show phenotypic differences from each other: 
A/J mice display a later age of onset and a slower progres-
sion of the muscle disease than SJL/J mice5. Our previous 
study showed that there were differences in the progress and 
prevalent site of skeletal muscle lesions between SJL/J and 
A/J mice8. In particular, the difference in sensitivity to mus-
cular dystrophic lesions between SJL/J and A/J mice was 
most apparent in the lumbar (longissimus and sublumbar) 
muscles. These findings support the hypothesis that addi-
tional enhancers or modifiers may be involved in the pro-
gression of skeletal muscle lesions in dysferlinopathy.
To shed some light on the molecular pathogenesis of 
dysferlinopathy, gene expression profiling studies have been 
undertaken in the skeletal muscles of SJL/J mice, C57BL/10.
SJL-Dysf mice and LGMD2B patients9–12. However, gene 
expression profiles of A/J mice or gene expression compari-
son studies between SJL/J and A/J mice have not yet to be 
reported. In this study, toward the goal of discovering ad-
ditional enhancers or modifiers associated with phenotypic 
divergence between SJL/J and A/J mice, the temporal or 
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site-specific gene expression was analyzed by a quantitative 
real-time polymerase chain reaction (qRT-PCR) using Taq-
Man® Gene Expression Assays.
Materials and Methods
Animals
BALB/c mice were used as control because this strain 
does not show abnormality in the skeletal muscles by the 
age of 16 months and has been used as a control in the his-
topathological  examination  of  skeletal  muscles  in  SJL/J 
mice13. Male BALB/c mice and male SJL/J mice were ob-
tained from Charles River Laboratories Japan Inc. (Kanaga-
wa, Japan). Male A/J mice were purchased from Japan SLC, 
Inc. (Shizuoka, Japan). All mice were brought to the test 
facility (Safety Research Laboratory (Kashima), Mitsubishi 
Tanabe Pharma Corporation, Osaka, Japan) at the age of 4, 
7 or 8 weeks. These animals were housed in plastic cages in 
an animal room kept under controlled conditions (tempera-
ture of 23 ± 2 °C, humidity of 30 to 70%, ventilation of 12 
times or more per hour, lighting for 12 hours between 06:30 
to 18:30) in the test facility. The mice were given pelleted 
feed sterilized by 15-kGy gamma irradiation (CRF-1, Ori-
ental Yeast Co., Ltd., Tokyo, Japan) and industrial water ad 
libitum via an automatic water feeder.
All experimental procedures were approved by the An-
imal Ethics Committee of Mitsubishi Tanabe Pharma Cor-
poration and were conducted in accordance with the Experi-
mental Guide to the Care and Use of Laboratory Animals.
Histopathology
Three male mice from each strain were euthanized by 
exsanguination from the abdominal aorta under ether anes-
thesia at 10 and 30 weeks of age. The femoral, crural, bra-
chial, forearm, abdominal and lumbar muscles were fixed in 
10% neutral buffered formalin; skeletal muscles including 
bones were decalcified using 50% K-CX (Falma Co., Ltd., 
Tokyo,  Japan)  solution  for  decalcification,  processed  and 
embedded in paraffin. Tissue paraffin blocks were sectioned 
at a thickness of 2 µm, and each section was stained with 
hematoxylin and eosin (HE).
Quantitative real-time polymerase chain reaction 
(qRT-PCR) analysis
Genes that have been shown to change in the skeletal 
muscles of SJL/J mice, dystrophin-deficient mice or muscu-
lar dystrophy patients or to be linked to these gene expres-
sion changes were mainly selected for qRT-PCR analysis.
Lipid metabolism-associated genes: SJL/J mice have 
a mutation in the Tbc1d1 gene that results in a truncated 
protein  lacking  the  TBC  Rab–GTPase-activating  protein 
domain14 and showed increased fatty acid uptake/oxidation 
and reduced glucose uptake in isolated skeletal muscle. Un-
coupling protein-3 and -2 (Ucp3, Ucp2) gene expressions as 
candidate genes in the regulation of lipids as metabolic fuels 
in skeletal muscle15 were measured with that of peroxisome 
proliferative activated receptor-g coactivator 1a (PGC-1a) 
regulating the expression of many genes involved with fatty 
acid oxidation16.
Skeletal  muscle  atrophy-associated  genes:  Myostatin 
as  an  endogenous  negative  regulator  of  muscle  growth17 
and follistatin as an endogenous antagonist of myostatin18, 
which have attracted attention as therapeutic targets of mus-
cular disorders19, were quantified.
Ubiquitin-proteasome system-associated genes, ubiq-
uitin-like protein gene and ER stress-associated genes: Nor-
mal dysferlin was degraded by an endoplasmic reticulum 
(ER)-associated degradation system (ERAD) composed of 
ubiquitin/proteasome. However, mutant dysferlin spontane-
ously aggregated in the ER and induced eukaryotic trans-
lation  initiation  factor  2  alpha  phosphorylation  and  LC3 
conversion, a key step for autophagosome formation, and, 
finally, ER stress cell death20. Because SJL/J mice produce 
incomplete dysferlin protein, ERAD and ER stress-associ-
ated genes were included in the examination of gene expres-
sion.
Heat  shock  protein  genes:  An  in  vitro  study  using 
mouse skeletal muscle myotubes indicated that an increased 
level of heat shock proteins (HSPs) may provide protection 
against the muscle damage that occurs by a pathological in-
crease in intracellular calcium or uncoupling of the mito-
chondrial respiratory chain21. Some HSPs were selected as 
targets for evaluation of the protective system in the skeletal 
muscles of SJL/J and A/J mice.
ER-associated degradation of glycoprotein-associated 
genes: It is known that major histocompatibility complex 
(MHC) class I expression is markedly upregulated in myo-
pathic muscles of dysferlin-deficient SJL/J mice22. The as-
sembly and folding of MHC class I molecules are associated 
with calnexin, calreticulin and ERp5723. Transcriptional in-
duction of the ER degradation enhancer mannosidase alpha-
like 1 (Edem1) is required for degradation of misfolded gly-
coprotein substrates including MHC class I24. To confirm 
whether or not excess MHC class I causes the upregulation 
of glycoprotein ERAD, these gene expression profiles of 
SJL/J and A/J mice were determined.
Histone deacetylase genes and nitric oxide synthase 
genes: Histone deacetylase inhibitors and nitro oxide donors 
delay the progression of muscular dystrophy in dystrophin-
deficient mice25,26. Because histone deacetylase and nitro 
oxide may be related to the development of dystrophic le-
sions in SJL/J and A/J mice, these gene expressions in SJL/J 
and A/J mice were compared with those of BALB/c mice.
Oxidative stress-associated genes: Absence of dystro-
phin appears to render muscle specifically more susceptible 
to oxidative stress27. Heme oxygenase 1 (Hmox1) is known 
to be induced by oxidative stress or other stress stimuli28. 
Thioredoxin reductase 1 (Txnrd1) is a key enzyme in the 
thioredoxin system as an anti-oxidation system29. To ex-
plore the relationship between oxidative stress and muscle 
damage in dysferlin-deficient mice, these gene expression 
levels were quantified in SJL/J and A/J mice.
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Complement  control  factor  genes:  SJL/J  mice  were 
found  to  exhibit  downregulation  of  the  complement  in-
hibitor,  decay-accelerating  factor  1  (Daf1)/CD55  antigen, 
in skeletal muscle only, and the absence of Daf1/CD55 in-
creased susceptibility to complement attack in cultured hu-
man myotubes30. Daf1 and Daf2 were selected for quantifi-
cation by qRT-PCR on the basis of these findings.
Three mice each at 10 and 30 weeks of age were pre-
pared for qRT-PCR analysis separately from histopathologi-
cal examination. The femoral (rectus femoris) and lumbar 
(longissimus lumborum) muscles were removed from mice, 
quickly cut into slices less than 0.5-cm thick and incubated 
overnight  in  RNAlater  RNA  Stabilization  Reagent  (Qia-
gen,  Valencia,  CA,  USA)  at  2–8 °C.  The  rectus  femoris 
and longissimus lumborum, in which there was shown to 
be a remarkable difference of severity of muscle lesions be-
tween SJL/J and A/J mice at the age of 35 weeks old in our 
previous report8, were used as examined sites in the first 
qRT-PCR analysis. The tissue samples in the reagent were 
transferred to a freezer at -20 °C and stored until use. For 
qRT-PCR analysis, total RNA was isolated from each isolat-
ed muscle with an RNeasy® Fibrous Tissue Mini Kit (Qia-
gen) according to the instructions of the manufacturer. For 
each sample, pooled total RNA from 3 mice was reverse-
transcribed using a High Capacity RNA-to-cDNA Kit (Ap-
plied Biosystems, Foster City, CA, USA). The gene-specific 
primers and probes used for qRT-PCR analysis were avail-
able as TaqMan® Gene Expression Assays (Applied Biosys-
tems; Table 1). The qRT-PCR reactions were performed on 
a 7500 Fast Real-Time PCR System (Applied Biosystems) in 
20 µL of the reaction mixture containing 1x TaqMan Fast 
Universal PCR Master Mix, No AmpErase® UNG (Applied 
Biosystems), 1x Gene Expression Assay mix and 5 µL of di-
luted cDNA sample as a template. MicroAmp® Fast 96-Well 
Reaction Plates covered by optical adhesive covers (Applied 
Biosystems) were used. Amplification was conducted ac-
cording to the following thermal profile: 1 cycle at 95 °C 
for 20 sec, and 40 cycles at 95 °C for 3 sec and 60 °C for 
30 sec. Initial raw data analysis was performed using the 
Sequence Detection Software version 1.3.1. Relative mRNA 
levels were calculated by the comparative threshold cycle 
(Ct) method31,32, as described in Applied Biosystems User 
Bulletin Number 2 (P/N 4303859).
The program calculates DCt and DDCt with the follow-
ing formula: DDCt = DCt sample [Ct endogenous control 
gene (from BALB/c mice at 30 weeks of age, SJL/J or A/J 
mice) - Ct target gene (from BALB/c mice at 30 weeks of 
age, SJL/J or A/J mice)] - DCt control [Ct endogenous con-
trol gene (from BALB/c mice at 10 weeks of age) - Ct target 
gene (from BALB/c mice at 10 weeks of age)]. The relative 
gene expression was calculated using the expression 2–(DDCt). 
Glyceraldehyde-3-phosphate dehydrogenase (Gapdh) gene 
was selected as an endogenous control gene.
Quadruplicate measurements per gene were conducted 
and data are presented as the mean and standard deviation. 
Changes in gene expression are reported as fold changes 
relative to those of controls (the Ct values in BALB/c mice 
at the age of 10 weeks). We defined that the gene expres-
sion was regulated or downregulated in the present study 
if the relative gene expression was more than twice or less 
than one-half that of the control, respectively. Data were not 
statistically analyzed because qRT-PCR analysis was per-
formed using pooled samples of equal quantities of total 
RNA obtained from three mice in each strain.
Additional qRT-PCR analysis
To clarify the site-specificity and temporal changes of 
gene expression, some genes that were upregulated more 
than twice or downregulated less than one-half that of the 
control in both rectus femoris and longissimus lumborum, 
in one of SJL/J and A/J mice on the first qRT-PCR analysis, 
and other genes associated with these genes (Table 2), were 
measured in eight sites of striated muscles (rectus femoris, 
gastrocnemius, triceps brachii, flexor carpi ulnaris, longis-
simus lumborum, abdominal muscle, diaphragm and heart) 
from three mice at the ages of 5, 15 and 30 weeks old by 
means of the above method. The eight striated muscles used 
for additional qRT-PCR analysis are separated into three 
groups based on the severity of muscle pathological lesions 
in SJL/J mice at an age of 35 weeks old8. The rectus femoris, 
longissimus lumborum and abdominal muscle are included 
in the severe lesion group, which exhibits slight to moderate 
degeneration/necrosis with moderate central nuclei in mus-
cle fibers. The triceps brachii are referred to as the slight 
lesion group, which shows minimal degeneration/necrosis 
with moderate central nuclei in muscle fibers. Other muscles 
are classified in the minimal lesion group, with only mini-
mal degeneration/necrosis with slight central nuclei or with-
out central nuclei in muscle fibers.
Lipid metabolism-associated genes: As previously ex-
plained, SJL/J mice have a mutation in the Tbc1d1 gene. 
Checks were performed to ensure that the Tbc1d1 gene had 
not been expressed at any week of age or at any muscle site.
Apoptosis-associated gene: It was reported that Ucp2 
increases the sensitivity of adult rat cardiomyocytes to hy-
poxia-reoxygenation by way of ATP depletion and acidosis, 
which in turn causes accumulation of proapoptotic protein 
Bcl-2 and 19-kDa interacting protein 3 (Bnip3)33. In the first 
qRT-PCR analysis, the gene expression levels of Ucp2 in the 
rectus femoris and longissimus lumborum of SJL/J mice at 
the age of 30 weeks old were higher than those of the con-
trol. Therefore, Bnip3 gene expression level was measured 
to explore the mechanism of degeneration/necrosis in skel-
etal muscle fibers.
Calcium binding protein gene: In muscular lesions in 
SJL/J mice, most infiltrating cells are F4/80 antigen-positive 
macrophages8. Recently, it was demonstrated that S100 cal-
cium binding protein A4 (S100A4), a member of the S100 
family of Ca2+ binding proteins, mediates macrophage re-
cruitment and chemotaxis in vivo34. Therefore, to find an as-
sociation between the severity of muscle lesions and S100A4 
gene expression levels, qRT-PCR analysis was conducted 
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using the eight striated muscles separated into three groups 
based on the severity of muscle lesions in SJL/J mice at an 
age of 35 weeks old8.
Immunologically relevant gene: It is known that MHC 
class I (H2-K1) expression is markedly upregulated in myo-
pathic muscles of dysferlin-deficient SJL/J mice22. There-
fore, to ascertain whether or not H2-K1 gene expression was 
systemically upregulated, H2-K1 gene expression level was 
examined by qRT-PCR analysis.
Telomere-associated genes: Telomere shortening was 
found in tibialis anterior and diaphragm muscles from mdx 
mice  in  comparison  with  age-matched  wild-type  mice35. 
Table 1.  TaqMan® Gene Expression Assays (Gene-specific Primers and Probes) used in qRT-PCR for the Rectus Femoris 
and Longissimus Lumborum from Mice at 10 and 30 Weeks of Age
Gene name [Synonym] Gene symbol Assay ID
Housekeeping genes
Glyceraldehyde-3-phosphate dehydrogenase Gapdh Mm99999915_g1
Lipid metabolism-associated genes
Peroxisome proliferative activated receptor, gamma, coactivator 1 alpha Ppargc1a Mm00731216_s1
Uncoupling protein 2 (mitochondrial, proton carrier) Ucp2 Mm00627599_m1
Uncoupling protein 3 (mitochondrial, proton carrier) Ucp3 Mm01163394_m1
Skeletal muscle atrophy-associated genes
Myostatin Mstn Mm03024050_m1
Follistatin 1) Fst Mm03023987_m1
Ubiquitin-proteasome system-associated genes
F-box protein 32 [muscle atrophy F-box (MAFbx)/atrogin-1] Fbxo32 Mm00499523_m1
Tripartite motif-containing 63 [muscle RING-finger protein (MuRF1)] Trim63 Mm01185221_m1
Forkhead box O3 Foxo3 Mm01185722_m1
Ubiquitin-like protein gene
Ubiquitin-fold modifier 1 Ufm1 Mm00787190_s1
ER stress-associated genes
Heat shock protein 5 [immunoglobulin heavy-chain binding protein
(Bip)/78 kDa glucose-regulated protein (Grp78)]
Hspa5 Mm00517691_m1
Activating transcription factor 6 Atf6 Mm01295319_m1
DNA-damage inducible transcript 3
[C/EBP homologous protein (Chop)/Gadd153]
Ddit3 Mm00492097_m1
Heat shock protein genes
Heat shock protein 1 [Hsp25] Hspb1 Mm00834384_g1
Heat shock protein 1B [Hsp70] Hspa1b Mm03038954_s1
Heat shock protein 90, beta (Grp94), member 1 [Grp94] Hsp90b1 Mm00441926_m1
DnaJ (Hsp40) homolog, subfamily B, member 1 [Hsp40] Dnajb1 Mm00444519_m1
ER-associated degradation of glycoproteins-associated genes
ER degradation enhancer, mannosidase alpha-like 1 Edem1 Mm00551797_m1
Protein disulfide isomerase associated 3 [ERp57] Pdia3 Mm00433130_m1
Calnexin Canx Mm00500330_m1
Calreticulin Calr Mm00482936_m1
Histone deacetylase genes
Histone deacetylase 1 1) Hdac1 Mm02745760_g1
Histone deacetylase 2 1) Hdac2 Mm00515117_m1
Histone deacetylase 3 1) Hdac3 Mm00515916_m1
Histone deacetylase 8 1) Hdac8 Mm01224980_m1
Nitric oxide synthase genes
Nitric oxide synthase 1, neuronal [nNOS] 1) Nos1 Mm00435175_m1
Nitric oxide synthase 2, inducible [iNOS] 1) Nos2 Mm01309898_m1
Nitric oxide synthase 3, endothelial cell [eNOS] 1) Nos3 Mm00435204_m1
Oxidative stress-associated genes
Heme oxygenase (decycling) 1 Hmox1 Mm00516004_m1
Thioredoxin reductase 1 Txnrd1 Mm00443675_m1
Complement control factor genes
CD55 antigen [Daf1] Cd55 Mm00438377_m1
Decay accelerating factor 2 Daf2 Mm00432792_g1
1) These genes were profiled in only the rectus femoris.53   Kobayashi, Izawa, Kuwamura et al.
In addition, it was documented that telomeric repeat bind-
ing  factor-1  (Terf1)  and  poly  (ADP-ribose)  polymerase-1 
(Parp1), which control telomere elongation, were overex-
pressed in the muscles of Duchenne muscular dystrophy36. 
It was ascertained whether or not two telomere elongation 
control factors were overexpressed in the skeletal muscles of 
two dysferlinopathy model mice by qRT-PCR.
Triplicate measurements for each gene were conducted 
and data are presented as the mean and standard deviation. 
Changes in gene expression are described as fold changes 
relative to that of controls (the Ct values in BALB/c mice at 
the age of 5 weeks).
Results
Histopathology
The  results  of  histopathological  examination  corre-
sponded to our published data8. Fig. 1 shows typical his-
topathological findings in the femoral muscles of BALB/c, 
SJL/J and A/J mice at 10 and 30 weeks of age.
In brief, at 10 weeks of age, no significant changes 
were observed in the skeletal muscle fibers of BALB/c and 
A/J mice, and some skeletal muscles (particularly femoral, 
brachial, abdominal and lumbar muscles) showed minimal 
degeneration and/or necrosis of muscle fibers in SJL/J mice. 
At 30 weeks of age, BALB/c mice did not exhibit histopath-
ological changes in any skeletal muscles. However, the his-
topathological lesions of skeletal muscles in SJL/J mice pro-
gressed in severity and were increasingly frequent with age, 
and  SJL/J  mice  revealed  macrophage  infiltration  around 
degeneration and/or necrosis of muscle fibers. In contrast, 
histological lesions of these skeletal muscles in A/J mice 
showed a slow progression with age.
qRT-PCR
Tables 3 and 4 show the results of qRT-PCR analysis.
The first qRT-PCR analysis revealed genes that were 
upregulated more than twice or downregulated less than 
one-half that of the control in both rectus femoris and lon-
gissimus lumborum in one of SJL/J and A/J mice.
Ucp2 as a lipid metabolism-associated gene was up-
regulated in the rectus femoris and longissimus lumborum 
of SJL/J mice and downregulated in the longissimus lumbo-
rum of A/J mice at 30 weeks of age.
The  gene  expression  level  of  heat  shock  protein  70 
(Hsp70) in the rectus femoris and longissimus lumborum 
of BALB/c mice at 30 weeks of age was more than 30 times 
higher than that of the control. The gene expression level 
of heat shock protein 40 (Hsp40), which is known to be a 
co-chaperone regulating Hsp70, in the rectus femoris and 
longissimus lumborum of BALB/c mice at 30 weeks of age 
was also more than four times higher than that of the con-
trol. Hsp70 was upregulated in the rectus femoris and lon-
gissimus lumborum of SJL/J mice at 10 and 30 weeks of age 
Table 2.  TaqMan® Gene Expression Assays (Gene-specific Primers and Probes) used in qRT-PCR for the Skeletal Muscles 
from Mice at 5, 15 and 30 Weeks of Age
Gene name [Synonym] Gene symbol Assay ID
Housekeeping gene
Glyceraldehyde-3-phosphate dehydrogenase Gapdh Mm99999915_g1
Lipid metabolism-associated genes
Uncoupling protein 2 (mitochondrial, proton carrier) Ucp2 Mm00627599_m1
TBC1 domain family, member 1 [TBC1D1]1) Tbc1d1 Mm00497989_m1
Heat shock protein genes
Heat shock protein 1B [Hsp70] Hspa1b Mm03038954_s1
DnaJ (Hsp40) homolog, subfamily B, member 1 [Hsp40] Dnajb1 Mm00444519_m1
ER-associated degradation of glycoproteins-associated genes
ER degradation enhancer, mannosidase alpha-like 1 Edem1 Mm00551797_m1
Protein disulfide isomerase associated 3 [ERp57] Pdia3 Mm00433130_m1
Oxidative stress-associated gene
Heme oxygenase (decycling) 1 Hmox1 Mm00516004_m1
Complement control factor gene
CD55 antigen [Daf1] Cd55 Mm00438377_m1
Apoptosis-associated gene
Bcl-2 and 19-kDa interacting protein 31) Bnip3 Mm01275601_g1
Calcium binding protein gene
S100 calcium binding protein A41) S100a4 Mm00803372_g1
Immunologically-relevant gene
Histocompatibility 2, K1, K region [H2-K1]1) H2-K1 Mm01612247_mH
Telomere-associated genes
Telomeric repeat binding factor 11) Terf1 Mm00436923_m1
Poly (ADP-ribose) polymerase family, member 11) Parp1 Mm01321084_m1
1) Added TaqMan® Gene expression assays (gene-specific primers and probes).54 Comparative Gene Expression Analysis in Dysferlin-deficient Mice
Fig. 1.  Histopathology of the rectus femoris in BALB/c, SJL/J and A/J mice. At 10 weeks of age (upper figures), no significant changes are 
observed in the skeletal muscle fibers of BALB/c (A) and A/J mice (C), and a few muscle fibers show minimal degeneration with mono-
nuclear cell infiltration in SJL/J mice (B). At 30 weeks of age (lower figures), BALB/c mice do not exhibit histopathological changes in 
any skeletal muscles (D). The histopathological lesions of skeletal muscles in SJL/J mice progress in severity with age and are character-
ized by the following findings: degenerative/necrotic muscle fibers, centronuclear muscle fibers, fatty infiltration and variation in size of 
muscle fibers (E). The muscle fibers in A/J mice show only degenerative/necrotic features and variation in size (F). HE staining. Bar: 100 
mm.
Table 3.  Relative Expression Levels of mRNAs in The Rectus Femoris of BALB/c, SJL/J and A/J Mice55   Kobayashi, Izawa, Kuwamura et al.
more than 10 times higher than that of the control. Likewise, 
Hsp40 was upregulated in the rectus femoris and longissi-
mus lumborum of SJL/J mice at 10 weeks of age more than 
three times higher than that of the control. However, the 
gene expression levels of Hsp70 and Hsp40 in SJL/J mice 
were lower than those of BALB/c mice at 30 weeks of age. 
Hsp70 and Hsp40 were downregulated in the longissimus 
lumborum or rectus femoris of A/J mice at 30 weeks of age 
compared with those of the control.
Edem1 mRNA in the rectus femoris and longissimus 
lumborum,  and  ERp57  mRNA  in  the  longissimus  lum-
borum showed high expression levels in SJL/J mice at 30 
weeks of age compared with those of the control.
The expression level of Hmox1 mRNA in the rectus 
femoris  and  longissimus  lumborum  of  SJL/J  mice  at  30 
weeks of age was more than two times higher than that of 
the control.
The gene expression level of Daf1/CD55 in the rectus 
femoris and longissimus lumborum of SJL/J mice at 10 and 
30 weeks of age was lower than that of the control.
Additional qRT-PCR
Tables 5 to 7 show the results of an additional qRT-
PCR analysis. Fig. 2 indicates the changes of principal genes 
in the tested muscles.
Lipid metabolism-associated genes: Ucp2 gene expres-
sion showed a tendency to be upregulated with age in the 
rectus femoris and longissimus lumborum of SJL/J mice, 
but to be downregulated with age in other muscles of SJL/J 
mice and all muscles of BALB/c and A/J mice. Tbc1d1 gene 
expression level in SJL/J mice was lowered regardless of 
age and site.
Heat shock protein genes: The gene expression levels 
of Hsp70 and Hsp40 in BALB/c mice peaked at 15 weeks of 
age. Hsp70 gene in the rectus femoris and heart of BALB/c 
mice exhibited a persistently higher expression level than 
that of the control. On the other hand, SJL/J mice showed 
upregulation of Hsp70 gene expression in the rectus femo-
ris, triceps brachii, longissimus lumborum and diaphragm 
at 30 weeks of age. The gene expression levels of Hsp70 and 
Hsp40 in most muscles of A/J mice were lower than those 
of the control.
ER-associated degradation of glycoprotein-associated 
genes: The rectus femoris and longissimus lumborum of 
SJL/J mice showed a tendency toward an increase in the 
gene expression levels of Edem1 and ERp57 at 30 weeks 
of age.
Oxidative  stress-associated  genes:  Hmox1  gene  ex-
pression level was increased with age in the longissimus 
lumborum of SJL/J mice, and there was a trend for an in-
crease in its level in the rectus femoris of SJL/J mice at 30 
weeks of age.
Complement control factor genes: Daf1/CD55 gene ex-
pression level in BALB/c mice showed a trend to increase by 
15 weeks of age. In contrast, SJL/J mice exhibited a marked 
lowering of Daf1/CD55 gene expression level in the limb, 
lumbar and abdominal muscles at all ages. There was no 
abnormality in the gene expression levels of Daf1/CD55 in 
all muscles of A/J mice and in the heart of SJL/J mice in 
comparison to that of the control.
Table 4.  Relative Expression Levels of MRNAs in The Longissimus Lumborum of BALB/c, SJL/J and A/J Mice56 Comparative Gene Expression Analysis in Dysferlin-deficient Mice
Fig. 2.  The changes of principal genes in each muscle site of BALB/c, SJL/J and A/J mice. The presented genes (Ucp2, Hmox1, 
Hsp70, S100A4 and Daf1/CD55) are those for which the changes are suspected of involvement in muscular lesions ob-
served in SJL/J and A/J mice. The severity of muscular lesions is as follows: lumbar muscle (longissimus lumborum) > 
femoral muscle (rectus femoris) > abdominal muscle > brachial muscle (triceps brachii) > crural muscle (gastrocnemius) 
> forearm muscle (flexor carpi ulnaris) > diaphragm. Ucp2 gene expression in the rectus femoris and longissimus lum-
borum of SJL/J mice shows a tendency to be upregulated with age. Hmox1 gene expression in the rectus femoris and 
longissimus lumborum of SJL/J mice is upregulated at 30 weeks of age. Hsp70 gene expression levels in most muscles 
of A/J mice are lower at all ages. S100A4 gene expression in the rectus femoris, longissimus lumborum and abdominal 
muscles of SJL/J mice is upregulated at 30 weeks of age. Daf1/CD55 gene expression in all studied muscles except for the 
heart of SJL/J mice shows a marked downregulation at all ages.57   Kobayashi, Izawa, Kuwamura et al.
Apoptosis-associated genes: Bnip3 mRNA level was 
sporadically increased in BALB/c mice and was temporally 
increased in the heart in A/J mice with age.
Calcium  binding  protein  genes:  The  rectus  femoris, 
longissimus  lumborum  and  abdominal  muscles  of  SJL/J 
mice showed an increase in S100A4 gene expression level 
with age.
Immunologically relevant genes: H2-K1 gene was sig-
nificantly expressed in SJL/J and A/J mice regardless of age 
and site.
Telomere-associated genes: Terf1 and Parp1 gene ex-
pression levels in SJL/J and A/J mice showed no alteration 
in any site or age compared with those of the control.
Discussion
This study showed that there were interstrain and site-
dependent  differences  in  the  gene  expression  profiles  of 
skeletal muscles in dysferlinopathy model mice, SJL/J and 
A/J mice.
Upon analysis by qRT-PCR, Tbc1d1 gene expression 
level in SJL/J mice was lowered regardless of age by a mu-
tation in the Tbc1d1 gene responsible for increased fatty 
acid  uptake/oxidation  and  decreased  glucose  uptake14.  In 
quantitative analysis of the gene expression levels of PGC-
1a, Ucp2 and Ucp3 as lipid metabolism-associated genes, 
mRNA expression level of Ucp2 showed a trend to be upreg-
ulated in the rectus femoris and longissimus lumborum of 
SJL/J mice at 30 weeks of age in contrast to those of BALB/c 
and A/J mice. Forced expression of Ucp2 in pancreatic islets 
was found to result in decreased ATP content, and the islet 
cells of UCP2 knockout mice showed increased ATP level37. 
Overexpression of UCP2 in primary cardiomyocytes led to a 
significant decline in ATP level and enhanced sensitivity to 
hypoxia-reoxygenation33. Ucp2-mediated energy loss may 
be related to muscle degeneration/necrosis in SJL/J mice. 
Tbc1d gene-deficient cells exhibited inhibited trafficking of 
glucose transporter GLUT4 from intracellular vesicles to 
plasma membrane38, which is suggested to show a decrease 
in intracellular glucose level and a subsequent enhancement 
of fatty acid oxidation. As a result, the skeletal muscles in 
SJL/J mice are likely to have uncoupling.
Most  upregulation  of  Edem1,  ERp57,  Hmox1  and 
S100A4 was observed in the rectus femoris, longissimus 
lumborum or abdominal muscles, in which dystrophic le-
sions occur more commonly in SJL mice. These upregula-
tions approximately coincide with the occurrence of dystro-
phic changes in these sites.
Edem1 is needed for degradation of misfolded glycopro-
tein substrates including MHC class I24. ERp57 contributes 
to the formation of native disulfide bonds in nascent MHC 
class I heavy chains24. SJL/J mice show marked upregula-
tion of MHC class I expression in myopathic muscles22. In 
fact, the expression level of MHC class I (H2-K1) gene in 
the rectus femoris and longissimus lumborum of SJL/J mice 
was significantly higher regardless of age and site compared 
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with those of A/J and BALB/c mice in our study. Therefore, 
gene changes of Edem1 and ERp57 in SJL/J mice may be 
associated with a very marked upregulation of H2-K1 ex-
pression in the rectus femoris and longissimus lumborum.
Hmox1 provides the first line of defense against oxida-
tive stress because it rapidly responds to oxidants39. How-
ever, Txnrd1, which is a part of the anti-oxidation system 
as well as Hmox1, was not upregulated in any muscles of 
SJL/J mice. Recently, calcium-dependent upregulation of 
Hsp70 and Hmox-1 in skeletal muscle cells or hepatocytes 
was reported40,41. Because dysferlin null muscle fibers are 
defective in Ca2+-dependent resealing of sarcolemma dis-
ruptions42, these muscle fibers may cause persistent calcium 
influx into the cytoplasm after membrane injury. The gene 
expression levels of Hmox1 were correlated with the sever-
ity of histopathological lesions in femoral (rectus femoris), 
lumbar  (longissimus  lumborum)  and  abdominal  muscles; 
calcium influx into the cytoplasm following muscle injury 
may induce Hmox1 gene expression. However, Hsp70 was 
also upregulated in the diaphragm of SJL/J mice, in where 
there were few histopathological changes at all examined 
times. In addition, change of Hsp70 gene expression level 
was not observed in the abdominal muscles of SJL/J mice, 
in which histopathological changes were found at 30 weeks 
of age. The above muscles and hearts without histopatho-
logical abnormalities in BALB/c mice exhibited upregula-
tion of this gene expression from 15 weeks of age. It was 
reported that significant increases in Hsp70 were observed 
at 12 weeks postpartum in normal rats43. The physiological 
gene expression mechanism of Hsp70 may develop some-
what later in these muscles excluding the heart of SJL/J 
mice. Therefore, an unknown factor other than persistent 
calcium influx may also cause Hmox1 induction in these 
muscles of SJL/J mice.
In contrast, the gene expression levels of Hsp70 in most 
muscles of A/J mice were lower than that of the control. 
Loss of fer-1, dysferlin homolog, in C. elegans causes down-
regulation of hsp-7044. It is possible that the downregulation 
of Hsp70 gene expression in the skeletal muscles of A/J mice 
is caused by the functional loss of dysferlin.
In muscle lesions in SJL/J mice, most infiltrating cells 
are F4/80 antigen-positive macrophages8. Recently, it was 
demonstrated that S100A4, a member of the S100 family of 
Ca2+-binding  proteins,  mediates  macrophage  recruitment 
and chemotaxis in vivo34. S100A4 upregulation in the rectus 
femoris and longissimus lumborum of SJL/J mice may be 
linked to muscle pathological characteristics in SJL/J mice.
SJL/J mice exhibited a marked lowering of Daf1/CD55 
gene expression level in all studied muscles except for the 
heart at all ages compared with that of BALB/c mice. In 
contrast, there was no predominant difference in the Daf1/
CD55 gene expression levels of A/J mice compared with 
that of BALB/c mice. It was reported that the gene expres-
sion of Daf1/CD55 as a complement inhibitor was down-
regulated in the skeletal muscles of LGMD2B patients or 
SJL/J mice30. Moreover, the serum concentration of the fifth 
component of complement (C5) in SJL/J mice is known to 
be significantly greater than that of other strains45. On the 
other hand, A/J mice are genetically deficient in C546. These 
results show the possibility that the difference in sensitiv-
ity to complement-dependent cytotoxicity causes the differ-
ence in phenotype between the two dysferlin-deficient mice. 
However, the downregulation of Daf1/CD55 alone cannot 
explain site-specificity of muscle lesions.
In LGMD2B patients or SJL mice, it is shown that 
MHC class I is overexpressed on muscle fibers22,47. Mean-
while, the results of study using SJL.129P2(B6)-B2mtm1Unc 
mice developed by targeted gene mutation of b-2-micro-
globulin, which is required for proper assembly of MHC 
class I proteins on the cell surface, revealed that MHC class 
I is not required for the appearance of spontaneous myopa-
thy in SJL/J mice22. Despite prolonged overexpression of 
MHC class I gene, there were few histopathological changes 
in the heart and diaphragm of SJL/J mice or A/J mice in our 
previous study8. Accordingly, it was suggested that upregu-
lation of MHC class I in SJL/J and A/J mice was not directly 
associated with the progression of dystrophic lesions.
This study showed that there were some interstrain dif-
ferences in the gene expression profiles of skeletal muscles 
between SJL/J and A/J mice (both dysferlinopathy model 
mice). The genes, the changes of which correlate with the 
severity of muscular lesion, were Ucp2, Hmox1 and S100A4 
in SJL/J mice. SJL/J mice showed a marked downregulation 
of Daf1/CD55 gene expression in all studied muscles except 
for the heart at all ages. The downregulation of Hsp70 gene 
expression was observed in the examined skeletal muscles of 
A/J mice. Further investigation is required to reveal whether 
alterations of their expression levels are the cause of dystro-
phic changes or occur subsequent to muscle damage.
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